Elsevier

World Neurosurgery

Volume 79, Issue 1, January 2013, Pages 97-98
World Neurosurgery

Perspectives
Desmoid Tumors

https://doi.org/10.1016/j.wneu.2011.07.033Get rights and content

References (4)

  • M.M. Gounder et al.

    Activity of sorafenib against desmoid tumor/deep fibromatosis

    Clin Cancer Res

    (2011)
  • H.S. Hosalkar et al.

    Musculoskeletal desmoid tumors

    J Am Acad Orthop Surg

    (2008)
There are more references available in the full text version of this article.

Cited by (4)

  • Desmoid tumors in neurosurgery: A review of the literature

    2015, Clinical Neurology and Neurosurgery
    Citation Excerpt :

    It has been suggested that the outcome of radiotherapy alone is equal to that of combined surgery and radiosurgery, though this remains unclear [15,25]. Pharmaceutical therapy including chemotherapy is controversial [31]. In the neurosurgical literature, DTs are only anecdotally described.

  • Desmoid type fibromatosis: A case report with an unusual etiology

    2017, World Journal of Gastrointestinal Oncology

Commentary on: Occiput to Thoracic Fusion After Surgical Resection of Desmoid Tumor by Hood et al. pp. 207.E15-207.E18.

Conflict of interest statement: Dr. Gokaslan holds stock in Spinal Kinetics and U.S. Spine, received grants and research funds from DuPuy, AO North America, Integra, NREF, Medtronic andhonoraria and fellowship support from AO Spine North America. Dr. Wolinsky and Dr. Laufer do not have any conflicts of interest to report that may be related to the content of this manuscript.

Ziya Levent Gokaslan, M.D., Professor, Department of Neurosurgery, Johns Hopkins University

View full text